Collaboration revenues — Total revenues
Neurocrine Biosciences Collaboration revenues — Total revenues decreased by 51.4% to $3.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 60.7%, from $8.90M to $3.50M. Over 4 years (FY 2021 to FY 2025), Collaboration revenues — Total revenues shows a downward trend with a -11.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful achievement of development milestones or strong commercial performance by partners, while a decrease may indicate fewer active collaborations or the conclusion of milestone-based payment cycles.
Detailed definition
Collaboration revenues represent income generated through strategic partnerships, licensing agreements, and joint develo...
Peer comparison
Peers in the biopharmaceutical industry often report similar income under 'license and collaboration revenue' or 'partnered revenue' lines, which are frequently subject to lumpy recognition patterns based on clinical trial outcomes.
nbix_segment_collaboration_revenues_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.10M | $7.20M | $8.50M | $5.60M | $26.20M | $8.60M | $7.40M | $5.10M | $6.40M | $7.00M | $8.00M | $6.30M | $6.40M | $5.50M | $6.50M | $8.90M | $5.50M | $5.00M | $7.20M | $3.50M |
| QoQ Change | — | -67.4% | +18.1% | -34.1% | +367.9% | -67.2% | -14.0% | -31.1% | +25.5% | +9.4% | +14.3% | -21.3% | +1.6% | -14.1% | +18.2% | +36.9% | -38.2% | -9.1% | +44.0% | -51.4% |
| YoY Change | — | — | — | — | +18.6% | +19.4% | -12.9% | -8.9% | -75.6% | -18.6% | +8.1% | +23.5% | +0.0% | -21.4% | -18.8% | +41.3% | -14.1% | -9.1% | +10.8% | -60.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's collaboration revenues — total revenues?
- Neurocrine Biosciences (NBIX) reported collaboration revenues — total revenues of $3.50M in Q1 2026.
- How has Neurocrine Biosciences's collaboration revenues — total revenues changed year-over-year?
- Neurocrine Biosciences's collaboration revenues — total revenues decreased by 60.7% year-over-year, from $8.90M to $3.50M.
- What is the long-term trend for Neurocrine Biosciences's collaboration revenues — total revenues?
- Over 4 years (2021 to 2025), Neurocrine Biosciences's collaboration revenues — total revenues has grown at a -11.5% compound annual growth rate (CAGR), from $43.40M to $26.60M.
- What does collaboration revenues — total revenues mean?
- Revenue earned from strategic partnerships and licensing agreements with other companies.